Clinical Trial Update: Neoadjuvant and Adjuvant Chemotherapy in High-risk Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

This update reports completion of a Phase 2 trial evaluating neoadjuvant and adjuvant chemotherapy for high-risk soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: Heidelberg University | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED